Abstract:Context: Polyamidoamine (PAMAM) dendrimers have attracted lots of interest as drug carriers. And little study about whether pluronic-attached PAMAM dendrimers could be potential drug delivery systems has been carried on. Objective: Pluronic F127 (PF127) attached PAMAM dendrimers were designed as novel drug carriers. Methods: Two conjugation ratios of PF127-attached PAMAM dendrimers were synthesized. H-1 nuclear magnetic resonance (H-1-NMR), Fourier transform infrared spectrum (FTIR), element analysis and ninhydrin assay were used to characterize the conjugates. Size, zeta potential and critical micelle concentrations (CMC) were also detected. And DOX was incorporated into the hydrophobic interior of the conjugates. Studies on their drug loading and drug release were carried on. Furthermore, hemolysis and cytotoxicity assay were used to evaluate the toxicity of the conjugates. Results and discussion: PF127 was successfully conjugated to the fifth generation PAMAM dendrimer at two molar ratios of 19% and 57% (PF127 to surface amine per PAMAM dendrimer molecular). The conjugates showed an increased size and a reduced zeta potential. And higher CMC values were obtained than pure PF127. Compared with unconjugated PAMAM dendrimer, PF127 conjugation significantly reduced the hemolytic toxicity and cytotoxicity of PAMAM dendrimer in vitro. The encapsulation results showed that the ability to encapsulate DOX by the conjugate of 19% conjugation ratio was better than that of 57% conjugation ratio. And the maximum is similar to 12.87 DOX molecules per conjugate molecule. Moreover, the complexes showed a sustained release behavior compared to pure DOX. Conclusion: Findings from the in vitro study show that the PF127-attached PAMAM dendrimers may be potential carriers for drug delivery.

Synthesis and Characterization of Phosphate Structured Dendrimers As Drug Delivery Carriers

Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.

Synthesis and Application of Dendrimers Based on Polyhedral Oligomeric Silsesquioxanes

Improving the gene transfection efficiency of polyethylenimine (PEI) based polyplex nanoparticles by cell cycle regulation

Dendrimers As Drug Carriers: Applications in Different Routes of Drug Administration

Dendritic Nanoglobules with Polyhedral Oligomeric Silsesquioxane Core and Their Biomedical Applications

Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery.

Preparation and characterization of N-phthaloyl-chitosan-g-(PEO–PLA–PEO) as a potential drug carrier

Synthesis of Degradable Bifunctional Dendritic Polymers As Versatile Drug Carriers

Dendritic phospholipid-based drug delivery systems

Facile Synthesis Of Polyester Dendrimers As Drug Delivery Carriers

Recent advances of dendrimers in delivery of genes and drugs.

Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics.

Molecular Level Precision and High Molecular Weight Peptide Dendrimers for Drug-Specific Delivery.

Nanostructured Calcium-based Biomaterials and their Application in Drug Delivery

Polyester Dendritic Systems for Drug Delivery Applications: Design, Synthesis, and Characterization

New Insights into the Interactions Between Dendrimers and Surfactants: 2. Design of New Drug Formulations Based on Dendrimer-Surfactant Aggregates

Tetrahedral DNA–mediated biomineralization of calcium carbonate nanoparticles for pH-responsive drug delivery

Synthesis of enzyme-responsive phosphoramidate dendrimers for cancer drug delivery

Applications Of Self-Assembled Polyphosphazene Nano-Aggregates In Drug Delivery

Polyamidoamine Dendrimers Surface-Engineered with Biomimetic Phosphorylcholine As Potential Drug Delivery Carriers